Showing results (1191-1200 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|May 17, 2022
PLGA-Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In VivoVinodh Kannappan, Ying Liu, Zhipeng Wang, et al.
Molecular Cancer Therapeutics|May 11, 2022
Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP SignalingXinxing Pan, Zhe Geng, Jingyun Li, et al.
Molecular Cancer Therapeutics|July 5, 2021
VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine DemethylasesThomas L Ekstrom, Nicholas M Pathoulas, Amelia M Huehls, et al.
Molecular Cancer Therapeutics|July 5, 2021
Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive CholangiocarcinomaKeiichiro Yokota, Satoshi Serada, Shigehiro Tsujii, et al.
Molecular Cancer Therapeutics|June 5, 2021
Venetoclax-based Rational Combinations are Effective in Models of MYCN-amplified NeuroblastomaKrista M Dalton, Kateryna Krytska, Timothy L Lochmann, et al.
Molecular Cancer Therapeutics|June 26, 2021
T-Cell Receptor Mimic Antibodies for Cancer ImmunotherapyZhijian Duan, Mitchell Ho
Molecular Cancer Therapeutics|March 12, 2020
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal CancerSanjay Goel, Allyson J Ocean, Ruwan Y Parakrama, et al.
Molecular Cancer Therapeutics|March 12, 2020
Inhibition of Importin β1 Augments the Anticancer Effect of Agonistic Anti-Death Receptor 5 Antibody in TRAIL-resistant Tumor CellsYuko Kojima, Takashi Nishina, Hiroyasu Nakano, et al.
Molecular Cancer Therapeutics|April 4, 2020
Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor ModelsAnita Kulukian, Patrice Lee, Janelle Taylor, et al.
Molecular Cancer Therapeutics|September 18, 2020
Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector FunctionRui Jin, Liang Liu, Yun Xing, et al.
Pageof 599